Prognostic 18F-flotufolastat PET parameters for outcome assessment of 177Lu-labeled PSMA-targeted radioligand therapy in metastatic castration-resistant prostate cancer

  • Amir Karimzadeh
  • , Kimberley Hansen
  • , Ergela Hasa
  • , Bernhard Haller
  • , Matthias M. Heck
  • , Robert Tauber
  • , Calogero D`Alessandria
  • , Wolfgang A. Weber
  • , Matthias Eiber
  • , Isabel Rauscher

Research output: Contribution to journal › Article › peer-review

1 Scopus citations

Fingerprint

Dive into the research topics of 'Prognostic 18F-flotufolastat PET parameters for outcome assessment of 177Lu-labeled PSMA-targeted radioligand therapy in metastatic castration-resistant prostate cancer'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science